• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺腺鳞癌:DNA分析、免疫组化病例报告及文献复习

Adenosquamous carcinoma of the prostate: case report with DNA analysis, immunohistochemistry, and literature review.

作者信息

Bassler T J, Orozco R, Bassler I C, Boyle L M, Bormes T

机构信息

UroDiagnostics Division, UroCor Inc., Oklahoma City, Oklahoma, USA.

出版信息

Urology. 1999 Apr;53(4):832-4. doi: 10.1016/s0090-4295(98)00418-x.

DOI:10.1016/s0090-4295(98)00418-x
PMID:10197870
Abstract

We diagnosed prostatic adenosquamous carcinoma by prostate core needle biopsy in a 55-year-old man with no history of prostate cancer. The prognosis, DNA analysis, and histogenesis of this extremely rare tumor are controversial. To our knowledge, this is the first case of adenosquamous carcinoma diagnosed by core needle biopsy in a patient with no history of prostate cancer or hormonal therapy. We performed immunohistologic and DNA analysis to further characterize this cancer. The clinical presentation and abnormal DNA analysis portend an aggressive course.

摘要

我们通过前列腺穿刺活检诊断出一名55岁、无前列腺癌病史男性患有前列腺腺鳞癌。这种极其罕见肿瘤的预后、DNA分析及组织发生存在争议。据我们所知,这是首例在无前列腺癌病史或激素治疗史的患者中通过穿刺活检诊断出的腺鳞癌病例。我们进行了免疫组织化学和DNA分析以进一步明确这种癌症的特征。临床表现及异常的DNA分析预示着病情进展迅速。

相似文献

1
Adenosquamous carcinoma of the prostate: case report with DNA analysis, immunohistochemistry, and literature review.前列腺腺鳞癌:DNA分析、免疫组化病例报告及文献复习
Urology. 1999 Apr;53(4):832-4. doi: 10.1016/s0090-4295(98)00418-x.
2
Adenosquamous carcinoma of the prostate.前列腺腺鳞癌。
Hum Pathol. 1995 Jan;26(1):123-6. doi: 10.1016/0046-8177(95)90125-6.
3
Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report.前列腺腺鳞癌循环肿瘤细胞的基因组分析:一例报告。
BMC Med Genomics. 2021 Sep 3;14(1):217. doi: 10.1186/s12920-021-01068-w.
4
Prostatic adenosquamous carcinoma metastasizing to testis.前列腺腺鳞癌转移至睾丸。
ScientificWorldJournal. 2006 Oct 2;6:2491-4. doi: 10.1100/tsw.2006.388.
5
Adenosquamous carcinoma of the prostate.前列腺腺鳞癌。
Yonsei Med J. 1999 Aug;40(4):396-9. doi: 10.3349/ymj.1999.40.4.396.
6
Adenosquamous carcinoma of the prostate: a case report.前列腺腺鳞癌:一例报告
Hum Pathol. 1991 Oct;22(10):1046-50. doi: 10.1016/0046-8177(91)90014-g.
7
Primary adenosquamous carcinoma of the prostate: a rare aggressive tumor.原发性前列腺腺鳞癌:一种罕见的侵袭性肿瘤。
Clin Genitourin Cancer. 2014 Feb;12(1):e29-31. doi: 10.1016/j.clgc.2013.08.006. Epub 2013 Oct 19.
8
Mixed Adenosquamous Cell Carcinoma of the Prostate with Paired Sequencing on the Primary and Liver Metastasis.前列腺混合性腺鳞状细胞癌,原发灶和肝转移灶均行配对测序。
Curr Oncol. 2024 Apr 24;31(5):2393-2399. doi: 10.3390/curroncol31050178.
9
Low-grade adenosquamous carcinoma of the breast--A case report with a BRCA1 germline mutation.乳腺低级别腺鳞癌——一例伴有 BRCA1 种系突变的病例报告。
Pathol Res Pract. 2010 Jul 15;206(7):511-3. doi: 10.1016/j.prp.2010.01.008. Epub 2010 Mar 1.
10
Adenosquamous carcinoma of the prostate.前列腺腺鳞癌。
Int Urol Nephrol. 1999;31(1):89-93. doi: 10.1023/a:1007180024991.

引用本文的文献

1
The diagnostic dilemma of squamous differentiation in prostate cancer: A case report.前列腺癌中鳞状分化的诊断困境:一例报告
Urol Case Rep. 2025 Apr 4;60:103034. doi: 10.1016/j.eucr.2025.103034. eCollection 2025 May.
2
Primary Adenosquamous Carcinoma of the Prostate.前列腺原发性腺鳞癌
Diagnostics (Basel). 2024 Mar 19;14(6):645. doi: 10.3390/diagnostics14060645.
3
Adenosquamous carcinoma of the prostate with low PSMA expression.前列腺腺鳞癌伴低前列腺特异性膜抗原(PSMA)表达。
Int Urol Nephrol. 2023 Mar;55(3):613-615. doi: 10.1007/s11255-022-03428-6. Epub 2022 Dec 20.
4
Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report.前列腺腺鳞癌循环肿瘤细胞的基因组分析:一例报告。
BMC Med Genomics. 2021 Sep 3;14(1):217. doi: 10.1186/s12920-021-01068-w.
5
Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment.促黄体生成素释放激素(LHRH)激动剂和放疗治疗后前列腺腺癌向鳞状细胞癌的转化。
Pan Afr Med J. 2019 Nov 1;34:125. doi: 10.11604/pamj.2019.34.125.19421. eCollection 2019.
6
Pathological transition as the arising mechanism for drug resistance in lung cancer.病理性转变作为肺癌耐药产生的机制。
Cancer Commun (Lond). 2019 Oct 1;39(1):53. doi: 10.1186/s40880-019-0402-8.
7
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.分子谱分析对治疗抵抗的转移性去势抵抗性前列腺癌的多种表型进行分层。
J Clin Invest. 2019 Jul 30;129(10):4492-4505. doi: 10.1172/JCI128212.
8
Diagnostic dilemmas of squamous differentiation in prostate carcinoma case report and review of the literature.前列腺癌中鳞状分化的诊断难题:病例报告及文献复习。
Diagn Pathol. 2011 May 31;6:46. doi: 10.1186/1746-1596-6-46.
9
Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate.25例原发性前列腺腺鳞癌患者的临床特征及预后
Rare Tumors. 2010 Sep 30;2(3):e47. doi: 10.4081/rt.2010.e47.